Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Frontiers in Pharmacology|April 16, 2021
Improving the Dysregulation of FoxO1 Activity Is a Potential Therapy for Alleviating Diabetic Kidney DiseaseYan Wang, Weichun HeKidney International|September 18, 2009
Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathyXiaoyue Tan, Weichun He, Youhua LiuHistology and Histopathology|November 7, 2019
The regulatory role of HIF-1 in tubular epithelial cells in response to kidney injuryYumei Qiu, Xiaowen Huang, Weichun HeFrontiers in Pharmacology|January 27, 2022
Emerging Therapeutic Strategies for Attenuating Tubular EMT and Kidney Fibrosis by Targeting Wnt/β-Catenin SignalingLichao Hu, Mengyuan Ding, Weichun HeNeural Plasticity|May 12, 2017
Rehabilitation Treatment and Progress of Traumatic Brain Injury DysfunctionBaoqi Dang, Wenli Chen, Weichun He, et al.The Journal of Biological Chemistry|December 30, 2010
Inhibition of proinflammatory RANTES expression by TGF-beta1 is mediated by glycogen synthase kinase-3beta-dependent beta-catenin signalingChunsun Dai, Xiaoyan Wen, Weichun He, et al.Journal of the American Society of Nephrology : JASN|October 30, 2010
Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injuryWeichun He, Young Sun Kang, Chunsun Dai, et al.Current Drug Targets|May 3, 2017
A Therapeutic Target of Cerebral Hemorrhagic Stroke: Matrix Metalloproteinase- 9Baoqi Dang, Xiaochun Duan, Zhong Wang, et al.ACS Applied Materials & Interfaces|January 7, 2015
One-pot synthesis of magnetic Ni@Mg(OH)2 core-shell nanocomposites as a recyclable removal agent for heavy metalsMeng Zhang, Weiqiang Song, Qiuling Chen, et al.Pageof 7